Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2021

Makhlouf Manal Mohamed, Radwan Eman Roshdy, Khorshed Ola Mohamed, Fathi Lamees Mohamed, Elmasry Manal Mohamed

Abstract excerpt

BACKGROUND: The chemokine receptor CXCR5 is selectively expressed on B cells; it is involved in lymphocyte homing and the development of normal lymphoid tissue. Its principle ligand is CXCL13 or B lymphocyte chemoattractant. Three polymorphisms in the CXCR5 gene, rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A, have been identified. OBJECTIVE: To assess the genetic polymorphisms of CXCR5 and evaluate their...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Egypt
Share to Genetic Predisposition to Disease
Share to Genotype
Share to Genotyping Techniques
Share to Lymphoma, Large B-Cell, Diffuse
Share to Polymorphism, Genetic
Share to Risk Factors

Source

Identifiers

PMID: 33378752
DOI: 10.1159/000510456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.PMID 33378752Read ↗

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.Semantic proximity Read ↗

C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.Semantic proximity Read ↗

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.Semantic proximity Read ↗

Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphomaSemantic proximity Read ↗

C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer.Semantic proximity Read ↗

The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma.Semantic proximity Read ↗

The single nucleotide polymorphism and haplotype analysis of MDR1 in Chinese diffuse large B cell lymphoma patients.Semantic proximity Read ↗

CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma.Semantic proximity Read ↗

[Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma].Semantic proximity Read ↗

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.Semantic proximity Read ↗

DNA Alterations in the Upstream Region of Exon 1 of OSBPL10 in Northern Thai Patients with Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.